Company & Sponsor Intelligence

University of Sao Paulo

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting0

Completed7

Countries1

Therapeutic footprint

adhdalzheimersautismdepressionpain_neuropathyptsd

Indexed studies

NCT04504877Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19
ptsd · BrazilPHASE2, PHASE3

NCT03356886Additional Effect of Pain Neuroscience Education to Spinal Manipulative Therapy in Chronic Low Back Pain
pain_neuropathy · BrazilNA

NCT02807870Early Interventions in Children With Attention Deficit/Hyperactivity Disorder
adhd · BrazilPHASE4

NCT03254992Real and Virtual Environments in Autism Spectrum Disorder
autism · BrazilNA

NCT01481558Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's Disease
alzheimers · BrazilPHASE2

NCT04518891Cognitive Functional Therapy Compared With Sham-treatment for Low Back Pain
pain_neuropathy · BrazilNA

NCT01962350Treatment of Bipolar Depression With H1-Coil Deep Brain rTMS: Clinical-Cognitive and Safety Evaluation
depression · BrazilNA

NCT01919892Longitudinal Study on the Neuroprotective and Neurotrophic Effects of Lithium
depression · BrazilPHASE4

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →